Rationale: RNA helicases, highly conserved enzymes, are currently believed to be not only involved in RNA modulation, but also in other biological processes. We recently reported that RNA helicase DDX (DEAD-box protein)-5 is required for maintaining the homeostasis of vascular smooth muscle cells (SMCs). However, the expression and function of RNA helicase in vascular physiology and disease is unknown.
1 DEAD-box proteins comprise the largest family of RNA helicases, which play critical roles in a broad array of biological processes such as cell growth and organ development, other than manipulating RNA structure. [2] [3] [4] The previous studies have established DDX (DEAD-box protein)-5 as a potential biomarker expressed in many cancer cell lines and an effective tumor promoter in numerous human cancers. [5] [6] [7] [8] It has been demonstrated that DDX-5 is required for DROSHA-mediated microRNA maturation in pulmonary artery smooth muscle cells (SMCs); and our recent report suggested that DDX-5 is pivotal for maintaining the contractile phenotype of SMCs, which both provide a potential link of RNA helicases to vascular cell biological behavior. 9, 10 However, the involvement of RNA helicases in vascular diseases remains elusive.
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Neointimal thickening and vascular stenosis are the 2 main characteristics of several vascular disorders, such as atherosclerosis, postangioplasty restenosis, late failure of vein grafting, and transplant vasculopathy. [11] [12] [13] Researches have shown that aberrant proliferation and migration of vascular SMCs are pivotal to intimal hyperplasia, and subsequently result in narrowing of the arterial lumen. 14, 15 Furthermore, use of antiproliferative reagents to antagonize intimal SMC proliferation has been considered as a potentially effective treatment for pathological vascular remodeling. 16 Yet, despite the importance of SMC biological behaviors in the modulation of vascular structure and function, the underlying mechanisms are incompletely understood.
Considering the positive association between phenotype transition and a high rate of proliferation/migration of SMCs, and their crucial role in multiple biological processes, we hypothesized that RNA helicases could be an important regulator in SMC misbehavior and arterial abnormality. The present study showed that DDX-5 was the most abundant DEAD-box protein expressed in human and rat arteries and mainly presented in SMCs. In addition, we observed an inverse correlation between DDX-5 expression and aberrantly SMC activation. Interestingly, we found that DDX-5 attenuated vascular SMC proliferation and migration, and prevented neointima formation, which contrasts with its well-known proproliferation or even oncogenic role in cancer progression. Our mechanistic study revealed that the observed effects were mediated, at least in part, by DDX-5-dependent protection of GATA (GATAbinding protein)-6, and subsequently elevated transcription of p27 Kip1 in SMCs. SMC-specific knockout of DDX-5 significantly influenced neointimal formation in the mouse models.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. Details of materials and experimental procedures are available in the Online Data Supplement.
Animals
All animal experimental procedures conformed to the guidelines of the Third Military Medical University Animal Care and Use Committee. SMC-specific DDX-5-deficient mice were generated by crossing flox/flox mice with SM22-Cre expressing animals. Successful deletion of DDX-5 in SMCs in vivo was confirmed by histological examination and Western blot analysis.
Rat Carotid Artery Injury Model
The methods for establishing a rat carotid artery balloon injury model and introducing lentivirus into the injured vessel have been previously described. 10 The arteries were harvested at indicated time points for the predesigned assays.
Mouse Femoral Artery Injury Model
The mouse femoral artery wire injury was performed as described previously. 17 Mouse left femoral arteries were carefully dissected and completely injured by using a guidewire. The wire-injured segments were collected at 4 weeks after surgery.
Results

Expression of DEAD-Box Proteins in Vessels
DEAD-box proteins comprise the largest and most extensively characterized family of helicases. We first defined the expression pattern of DEAD-box proteins in arteries. The quantitative real-time polymerase chain reaction (qRT-PCR) analysis revealed that DDX-5 was the most abundant DEADbox family member in normal human vessels and rat arteries ( Figure 1A ; Online Figure IA) . The mRNA levels of other DEAD-box proteins were much less than that of DDX-5, and DEAD-box protein 4 was almost absent in both human and rat vascular tissues. To determine the distribution of DDX-5 in artery, we compared its expression in endothelial cells and SMCs. Both qRT-PCR and Western blot analyses demonstrated that DDX-5 was more expressed in human vascular SMCs compared with cultured endothelial cells ( Figure 1B and 1C). In accordance with our prior observation, we found that DDX-5 was highly expressed DEAD-box member in SMCs ( Figure 1D) .
A recent study has defined a role of DDX-5 in the regulation of skeletal myogenesis. 18 We thus measured its expression within various muscle tissues and found that DDX-5 was abundantly expressed in rat cardiac and skeletal muscle, compared with rat carotid artery, aorta, and pulmonary artery ( Figure 1E and 1F What New Information Does This Article Contribute?
• DDX-5, the most abundant DEAD-box protein, is expressed in the arterial wall mainly located in SMCs.
• DDX-5 inhibits SMC proliferation, migration, and vascular remodeling.
• DDX-5 interacts with GATA (GATA-binding protein)-6 increasing its binding to the promoter of p27
Kip1
.
RNA helicases are involved in multiple cellular processes; however, their roles in vascular disease remain elusive. Our study shows that DDX-5, the most highly expressed RNA helicase DEAD-box protein member in the artery, can influence vascular SMC behavior and vascular remodeling. Mechanistically, DDX-5 directly binds to GATA-6, which enhances the recruitment of GATA-6 to p27 Kip1 promoter and increases p27 Kip1 expression. These findings highlight the importance of DDX-5 in modulating SMC biological properties and suggest DDX-5 as a potential therapeutic target in vascular diseases involving aberrant proliferation of SMCs. Figure 1 . DDX (DEAD-box protein)-5 is highly expressed in artery and smooth muscle cells (SMCs). A, Expression pattern of DEAD-box protein family in human artery was determined by quantitative real-time polymerase chain reaction (qRT-PCR). The mRNA levels were normalized to β-actin and then analyzed by comparing to DDX-5 (n=4). B and C, DDX-5 mRNA (B) and protein (C) levels in human vascular SMCs and endothelial cells (ECs) were evaluated by qRT-PCR and Western blot analysis, respectively (n=6; Mann-Whitney U test; *P<0.05). D, Expression pattern of DEAD-box protein family in human vascular SMCs was determined by qRT-PCR. The mRNA levels were normalized to β-actin and then analyzed by comparing to DDX-5 (n=6). E and F, DDX-5 mRNA (E) and protein (F) levels in various muscle tissues were evaluated by qRT-PCR and Western blot analysis, respectively (n=4; 1-way ANOVA; *P<0.05 compared with arteries). G-I, Representative immunofluorescent staining of DDX-5 in normal rat carotid artery (G; DDX-5, red fluorescence; ACTIN, green; 4′,6-diamidino-2-phenylindole [DAPI], nuclei stain, blue) and human vascular SMCs (H and I; DDX-5, red fluorescence; ACTIN, green; DAPI, nuclei stain, blue; n=4). Scale bars=50 μm (G and H) and 20 μm (I). and human vascular SMCs. As expected, immunofluorescence staining for DDX-5 predominated in the vessel media where SMCs were localized ( Figure 1G ; Online Figure IB ). This was confirmed at the cellular level analyzing cultured human vascular SMCs, which showed that SMCs contained DDX-5 that mainly located in the cell nucleus, whereas no fluorescence signals were detected in the cytoplasm ( Figure 1H and 1I) . The data demonstrated that DDX-5 is the mostly expressed RNA helicase DEAD-box protein in vascular tissue and cells.
Decreased Expression of DDX-5 in CytokineStimulated SMC and Pathological Vessel
To explore the relationship between DDX-5 and SMC biological properties, we evaluated its expression in the vessels from patients with atherosclerotic lesions (Figure 2A ; Online Figure II ). It was observed that DDX-5 displayed at higher level within the normal arteries and the media area of the pathological vessels, whereas DDX-5 staining was markedly decreased in the neointima regions. The finding from human sample was confirmed in the rat carotid injury model, which demonstrated a significant reduction of DDX-5 proteins in the injured arteries, by Western blot and immunofluorescence analyses ( Figure 2B and 2C) .
To verify the in vivo findings, cultured human vascular SMCs were exposed to various stimuli as described previously, 19 and the response of DDX-5 was determined through qRT-PCR ( Figure 2D ). We found that the mRNA level of DDX-5 in SMCs was significantly reduced following 24 hours incubation with proinflammatory cytokine TNF (tumor necrosis factor)-α and growth factor PDGF (platelet-derived growth factor)-BB. As shown in Figure 2E through 2G, decrease of DDX-5 protein level by PDGF-BB was concentration and time dependent, and maximal downregulation occurred with 50 ng/mL PDGF-BB for 24 hours. By contrast, reactive oxygen species H 2 O 2 and anti-inflammatory factor TGF (transforming growth factor)-β did not significantly alter DDX-5 mRNA expression. The observation of reduced DDX-5 in cytokine-treated SMCs was further strengthened by immunofluorescence study, which showed that PDGF-BB stimulation decreased DDX-5 protein level of vascular SMCs ( Figure 2H ). Altogether, our results indicate that DDX-5 expression is downregulated in cytokine-stimulated SMCs.
DDX-5 Inhibits SMC Proliferation and Migration
In an attempt to identify the potential role of DDX-5 in SMC biological function, we used specific small interfering RNA (siRNA)-mediated mRNA depletion to knockdown DDX-5 in human vascular SMCs. Control cells were transfected with lentivirus containing GFP (green fluorescent protein). As shown in Online Figure IIIA , transfection of DDX-5 siRNA caused an efficient abrogation of DDX-5 expression in SMCs. Accordingly, suppression of DDX-5 substantially enhanced serum and PDGF-BB-induced SMC proliferation, as evaluated by cell count and BrdU incorporation assay, whereas no effects of GFP lentivector on SMC growth status was observed compared with naive untransfected cells ( Figure 3A through  3C ). In addition, the modified Boyden chamber assay demonstrated that DDX-5 deficiency markedly facilitates SMC migration under PDGF-BB-stimulated condition (Online Figure   IIIB ). We evaluated cell apoptosis by flow cytometry, which showed that DDX-5 inhibition had no significant impacts on SMC apoptosis ( Figure 3D ). For DDX-5 gain-of-function experiments, lentivirus containing GFP or DDX-5-GFP constructs was applied, and overexpression of DDX-5 protein was verified by Western blot (Online Figure IIIC) . In agreement with the findings from the siRNA study, lentivirus-mediated enforced expression of DDX-5 markedly repressed SMC proliferation ( Figure 3E through 3G) . Furthermore, transfection of SMCs with DDX-5 lentivirus attenuated cell migration, as shown in Online Figure IIID . However, DDX-5 overexpression did not result in enhanced apoptosis of SMCs ( Figure 3H ).
The DEAD-box proteins are famous for their capacity of modulating RNA-related biological processes. To determine whether helicase activity is indispensable to the ability of DDX-5 to inhibit SMC proliferation and migration, the effect of a mutant DDX-5 protein was determined, in which the characteristic DEAD motif (required for helicase activity) was changed to NEAD. 20 Similar to our findings on wild-type DDX-5, SMCs transfected with DDX-5 mutant lentiviral plasmid had decreased proliferation and migration, implying that helicase activity seems to be dispensable for the protective effects of DDX-5 on SMCs (Online Figure IVA through IVC).
As cyclin-dependent kinase inhibitors, p27 Kip1 and p21
Cip1 play crucial roles in modulating SMC proliferation and neointimal hyperplasia. 21, 22 Moreover, recent study has suggested an essential role for p27
Kip1 in regulating SMC migration.
23,24
Therefore, we examined whether downregulation of DDX-5 was able to alter their expressions ( Figure 3I and 3J; Online Figure IVD and IVE). Western blot analysis showed that the level of p27 Kip1 protein was decreased dramatically in SMCs receiving DDX-5 siRNA compared with control cells, in contrast to cyclin D1 and proliferating cell nuclear antigen (PCNA), whereas no significant differences in p21
Cip1 protein expression were observed. Similarly, DDX-5 overexpression reversed PDGF-BB-mediated reduction of p27
Kip1 expression and repressed the upregulation of cyclin D1 and PCNA, but exerted no effects on p21
Cip1 level. Furthermore, DDX-5-mediated suppression of SMC proliferation was markedly attenuated in cells transfected with p27
Kip1 short hairpin RNA (Online Figure V) . Together, the findings suggest that DDX-5 is a novel regulator of SMC proliferation and migration.
DDX-5 Modulates GATA-6 Protein Production in SMCs
After observing the suppressive effects of DDX-5 on SMC proliferation and migration, we attempted to explore the potential mechanisms involved. This finding is interesting because the protective function of DDX-5 in SMCs is contradictory to the observations from oncology researches, which have indicated a deleterious role of DDX-5 in the development of various cancers. [5] [6] [7] [8] To explore the downstream target of DDX-5, we performed mass spectrometry analysis that identified 193 proteins potentiality interacting with DDX-5. Among these, GATA-6 has attracted our attention, which is a transcription factor closely associated with SMC growth and behavior. More interestingly, GATA-6 has been shown to prevent vascular SMC proliferation but promote cancer progression, thus, it possesses similar biological property as 25-29 Therefore, we wondered whether GATA-6 was a functional target protein of DDX-5 in SMCs.
To test this hypothesis, we first examined the potential impacts of DDX-5 on GATA-6 expression. Human vascular SMCs were transfected with either DDX-5 siRNA or overexpression lentivirus and their corresponding controls, and the levels of GATA-6 expression were determined by Western blot analysis ( Figure 4A and 4B) . Importantly, we found that DDX-5 downregulation led to prominent decrease of GATA-6 in SMCs, as compared with control. In contrast, enforced DDX-5 expression reversed PDGF-BB-induced repression of GATA-6, indicating a DDX-5-dependent mechanism. Similarly, increased GATA-6 protein was observed in DDX-5 mutant SMCs lacking the helicase activity (Online Figure  VIA) . Of note, manipulating DDX-5 expression by either siRNA or overexpression lentivirus transfection did not significantly affect GATA-6 mRNA level in SMCs, implicating that DDX-5 might directly modulate the protein expression of GATA-6 (Online Figure VIB and VIC) .
To further verify the potential link between DDX-5 and GATA-6, coimmunoprecipitation assay was conducted using the detergent extracts prepared from rat aorta and human vascular SMCs ( Figure 4C and 4D) . Western blot analysis of immunoprecipitates demonstrated a specific DDX-5 band brought down by GATA-6 antibody, but not by control IgG, either in vitro or in vivo. In agreement with this observation, coimmunoprecipitation with anti-DDX-5 antibody revealed that DDX-5 also precipitated GATA-6. This was strengthened by our immunofluorescence study that showed the colocalization of DDX-5 and GATA-6 in SMC nucleus ( Figure 4E ). Intriguingly, treatment of SMCs with cycloheximide did not significantly alter DDX-5 siRNA-mediated downregulation of GATA-6 expression, suggesting that DDX-5 depletion inhibited and degraded GATA-6 protein ( Figure 4F ). Thus, we applied the proteasome inhibitor MG132 to assess whether this effect was proteasome-mediated. Figure 4G showed that decrease of GATA-6 by DDX-5 interference was dramatically blocked at the presence of MG132. Furthermore, GATA-6 in DDX-5 knockdown SMCs had a shorter half-life than that in control SMCs (Online Figure VIIA) .
Next, we found that the ubiquitination of GATA-6 was increased in cells transfected with DDX-5 siRNA (Online Figure  VIIB) . After searching the UbiBrowser (http://ubibrowser. ncpsb.org), MDM (mouse double minute)-2 was predicted as the only E3 ubiquitin-protein ligase with high confidence interaction with GATA-6, which was confirmed by our coimmunoprecipitation assay showing an interaction between GATA-6 and MDM-2 (Online Figure VIIIA) . Our data demonstrated that DDX-5 deficiency significantly increased the binding of MDM-2 to GATA-6, whereas knockdown of MDM-2 reversed DDX-5 siRNA-induced downregulation of GATA-6 in SMCs (Online Figure VIIIB through VIIID) . In addition, we showed that the ubiquitination of GATA-6 was alleviated after MDM-2 knockdown (Online Figure VIIIE) . Collectively, these results implicate that DDX-5 directly targets GATA-6 and protects it from a proteasome-dependent degradation.
Effects of DDX-5 on SMC Proliferation Is Mediated by GATA-6
We next assessed the contribution of GATA-6 to the positive role of DDX-5 on SMC regulation. Although many published studies revealed that GATA-6-induced cell cycle arrest and maintained differentiated phenotype of SMCs, a recent study reported a contradictory finding, implicating that GATA-6 gene enhanced rat SMC proliferation and hypertrophy in a hypertension model. 30 In consideration of these disputes, we first tested its expression in human vessels, and found that GATA-6 protein was less detectable in SMCs of atherosclerosic lesions, compared with the media layer counterparts and the normal control ( Figure 5A ; Online Figure IX) . To further confirm the association between GATA-6 expression and SMC proliferation in vivo, we isolated balloon-injured rat carotid arteries at different time points. Western blot and immunofluorescence analyses demonstrated that balloon injury resulted in a significant downregulation of GATA-6 in the vascular wall ( Figure 5B and 5C). The findings were corroborated by the in vitro study, showing that PDGF-BB dose-and time-dependently decreased GATA-6 expression in human vascular SMCs ( Figure 5D and 5E). To determine the effects of GATA-6 on SMC biological characteristics, we established human vascular SMCs stably expressing GATA-6 siRNA or scrambled control using lentivirus. Accordingly, GATA-6 protein expression was significantly downregulated by specific siRNA, and SMC proliferation was evidently accelerated by GATA-6 inhibition (Figure 5F and 5G; Online Figure XA) . Moreover, knockdown of GATA-6 efficiently promoted PDGF-BB-induced SMC migration (Online Figure XB) . Additionally, transfection of SMCs with GATA-6 siRNA lentivirus was associated with downregulated p27
Kip1 but upregulated cyclin D1 and PCNA protein induction ( Figure 5H ).
To further investigate whether DDX-5-guided regulation of cell proliferation and migration was mediated by GATA-6, we transfected SMCs with DDX-5 overexpression lentivirus plus either scrambled or GATA-6 siRNA lentivirus. Importantly, we observed that gene depletion of GATA-6 abolished the protective effects of DDX-5 on SMC proliferation and migration, as evidenced by the BrdU and the modified Boyden chamber assays (Figure 5I and 5J; Online Figure  XC) . Given the observed positive correlation between GATA-6 and p27
Kip1
, we tested whether DDX-5 modulates p27
Kip1 expression in a GATA-6-dependent manner. In accordance with the proliferation study, transfection of DDX-5 lentivirus but not GFP control circumvented PDGF-BB-induced reduction of p27
Kip1 protein, whereas GATA-6 silencing largely inhibited the protective effect of DDX-5 on p27
Kip1 expression ( Figure 5K ). Furthermore, GATA-6 depletion abolished the inhibitory effects of DDX-5 on PDGF-BB-elicited upregulation of cyclin D1 and PCNA levels in SMCs. Our findings showed the involvement of a novel GATA-6/p27
Kip1 pathway in DDX-5-mediated regulation of SMC proliferation and migration. and PDGF (platelet-derived growth factor)-BB (C) were evaluated by BrdU incorporation (n=4; 1-way ANOVA; *P<0.05). D, Role of DDX-5 siRNA in SMC apoptosis was analyzed on a flow cytometer using annexin V and 7AAD staining (n=5; 2-tailed Student t test). E, Human vascular SMCs were transfected with GFP or DDX-5 lentivirus, and then cell number was measured by cell counts. (n=5; 1-way ANOVA; *P<0.05 compared with GFP virus; #P>0.05 compared with control). F and G, Effects of DDX-5 lentivirus on SMC proliferation stimulated by serum (F) and PDGF-BB (G) were evaluated by BrdU incorporation (n=4; 1-way ANOVA; *P<0.05). H, Role of DDX-5 lentivirus in SMC apoptosis was analyzed on a flow cytometer using annexin V and 7AAD staining (n=5; 2-tailed Student t test). I, Protein levels of p27 Kip1 , cyclin D1, and proliferating cell nuclear antigen (PCNA) in SMCs transfected with scrambled or DDX-5 siRNA were assessed by Western blot analysis (n=5; Mann-Whitney U test; *P<0.05). J, DDX-5 overexpression effects on p27 Kip1 , cyclin D1, and PCNA levels in human vascular SMCs (n=5; 1-way ANOVA; *P<0.05 compared with control; #P<0.05 compared with GFP virus).
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DDX-5 Increases the Binding of GATA-6 to the Promoter of p27
Kip1
We next tested if DDX-5 controlled p27 Kip1 gene expression at the transcriptional level. Total RNA of SMCs transfected with either DDX-5 siRNA or scrambled control was harvested and subjected to qRT-PCR analysis. Similar to the Western blot results, DDX-5 downregulation greatly suppressed p27
Kip1 mRNA expression ( Figure 6A ). Ectopic transfection with DDX-5 lentivirus significantly increased p27
Kip1 mRNA level compared to GFP lentivirus ( Figure 6B ). In addition, a GATA-6, red; DAPI, nuclei stain, blue; n=3). Scale bar=10 μm. F and G, SMCs transfected by scrambled or DDX-5 siRNA were treated with 10 μg/mL cycloheximide (F) or 10 nmol/mL MG132 (G) and then subjected to Western blot analysis (n=5; 1-way ANOVA; *P<0.05). PDGF indicates platelet-derived growth factor. Representative immunofluorescent staining of GATA-6 in human arteries (GATA-6, red fluorescence; ACTIN, green; DAPI, nuclei stain, blue). The white line indicated the boundary between the intima and the media (n=3). Scale bar=100 μm. B, Representative Western blot of GATA-6 protein expression in rat carotid arteries at 4, 7, and 14 d after injury (n=5; 2-tailed Student t test; *P<0.05). C, Representative immunofluorescent staining of GATA-6 in rat injured carotid artery (GATA-6, red fluorescence; ACTIN, green; DAPI, nuclei stain, blue). The white line indicated the boundary between the intima and the media (n=4). Scale bar=50 μm. D, Representative Western blot of GATA-6 expression in SMCs treated with different doses of PDGF (platelet-derived growth factor)-BB (n=4; 1-way ANOVA; *P<0.05). E, Protein levels of GATA-6 in human vascular SMCs treated with 25 ng/mL (Continued ) Figure 5 Continued. PDGF-BB at different times were analyzed by Western blot (n=4; 1-way ANOVA; *P<0.05). F and G, Effects of GATA-6 small interfering RNA (siRNA) on human vascular SMC proliferation stimulated with serum (F) and PDGF-BB (G) were evaluated by BrdU incorporation (n=4; 1-way ANOVA; *P<0.05). H, Protein levels of p27 Kip1 , cyclin D1, and proliferating cell nuclear antigen (PCNA) in SMCs transfected with scrambled or GATA-6 siRNA were assessed by Western blot (n=5; 2-tailed Student t test; *P<0.05). I and J, Effects of DDX-5 overexpression on human vascular SMC proliferation stimulated by serum (I) and PDGF-BB (J) in the presence or absence of GATA-6 siRNA (n=4; 1-way ANOVA; *P<0.05). K, Effects of DDX-5 overexpression on DDX-5, GATA-6, p27
Kip1 , cyclin D1, and PCNA levels in human vascular SMCs in the presence or absence of GATA-6 siRNA (n=4; 1-way ANOVA; *P<0.05 compared with no PDGF-BB control; #P<0.05 compared with GFP [green fluorescent protein] virus plus scrambled siRNA; §P<0.05 compared with DDX-5 virus plus scrambled siRNA). Kip1 gene expression in human vascular SMCs in the presence or absence of GATA-6 siRNA (n=5; 1-way ANOVA; *P<0.05 compared with GFP virus plus scrambled siRNA; #P<0.05 compared with DDX-5 virus plus scrambled siRNA). E and F, ChIP assays were performed using antibodies against GATA-6 in SMCs transfected with DDX-5 siRNA (E) or DDX-5 virus (F). Appropriate IgG was used as a negative control. PCR primers amplifying p27
Kip1 promoter were used. Aliquots of chromatin before immunoprecipitation served as an input control. Samples were subjected to qRT-PCR analysis (n=6; 1-way ANOVA; *P<0.05).
reduction of p27
Kip1 mRNA expression was found in SMCs transfected with GATA-6 siRNA lentivirus ( Figure 6C ). Of note, GATA-6 silencing inhibited the protective effect of DDX-5 on p27
Kip1 transcription ( Figure 6D ). Our data indicate that DDX-5 modulates p27
Kip1 mRNA expression via GATA-6. To clarify the molecular bases of GATA-6-mediated p27
Kip1 mRNA regulation, we investigated whether GATA-6 could interact directly with the regulatory regions of p27 Kip1 through ChIP experiment. After predicting the possible GATA-6-binding sites within p27
Kip1 promoter sequence using bioinformatics (Jaspar program), the ChIP assay confirmed the binding of GATA-6 to the predicted site on the p27 Kip1 promoter ( Figure 6E ). The findings were further supported by data from our luciferase activity assays using p27
Kip1 gene promoter reporter (Online Figure XD) . We showed that the luciferase activity of p27 Kip1 3′ UTR reporter was significantly repressed by GATA-6 siRNA. Moreover, chromatin prepared from scrambled control immunoprecipitated with antibodies against GATA-6 was enriched for p27 Kip1 promoter by almost 4-folds compared with level for SMCs transfected with DDX-5 siRNA lentivirus. In contrast, overexpression of DDX-5 dramatically promoted the binding of GATA-6 to p27
Kip1 promoter, which could be the consequence of enhanced GATA-6 level by DDX-5 ( Figure 6F ). Taken together, these results support a novel model in which DDX-5 enhances p27
Kip1 transcription by increasing the direct association of GATA-6 with p27
Kip1 promoter.
SMC-Specific Knockout of DDX-5 Promotes Neointima Formation
Abnormal proliferation of SMC is the biological foundation of pathological vascular remodeling such as neointimal hyperplasia in response to vascular injury or flow cessation. To determine the causative role of DDX-5 in SMC proliferation in vivo, we crossed DDX-5 flox/flox mice with SM22-Cre expressing animals for conditional DDX-5 deletion in SMCs. DDX-5 was undetectable in the vascular media of SMCspecific DDX-5-deficient mice, as assessed by immunostaining (Online Figure XIA) . In addition, Western blot analysis confirmed a significant reduction of DDX-5 protein in isolated arteries from SMC-specific DDX-5-deficient mice (Online Figure XIB) . Under normal condition, compared with control mice, SMC-specific DDX-5-deficient mice exhibited no alteration in systemic arterial pressure and the heart weight to body weight ratio, indicating that the ablation of DDX-5 has no apparent impact on circulation development and function (Online Figure XIC and XID) . Cell proliferation assays showed that vascular SMCs isolated from SMC-specific DDX-5-deficient mice exhibited greater proliferation compared with cells from the littermate controls ( Figure 7A and 7B). Similar to the findings in human cells, DDX-5 depletion significantly enhanced the migration ability of mouse SMCs (Online Figure XIE) . In accordance, GATA-6 and p27
Kip1 protein expressions were decreased, whereas PCNA expression was increased in SMCs isolated from SMC-specific DDX-5-deficient mice (Online Figure XIF) . We next exposed SMC-specific DDX-5-deficient mice to a femoral artery wire injury, and the neointimal formation was examined at 4-week postoperation. As shown in Figure 7C , the neointima as indicated by the area between the lumen and internal elastic lamina was evident in control mice after injury. In contrast, the neointima/media ratio and the neointimal area of SMC-specific DDX-5-deficient mice were substantially enlarged compared with that of controls ( Figure 7C through 7E). To further determine the contribution of DDX-5 deletion on SMC proliferation in vivo, Western blot and immunofluorescence staining were applied to investigating PCNA expression in the injured mouse femoral arteries ( Figure 7F and 7G ). There was a significant increase of PCNA in the neointima of SMC-specific DDX-5-deficient mice compared with control animals. Next, we tested whether the expression levels of GATA-6 and p27
Kip1 were altered in neointima of SMCspecific DDX-5-deficient mice ( Figure 7F, 7H, and 7I) . The data revealed a dramatic reduction of GATA-6 and p27
Kip1 in the neointimal area of SMC-specific DDX-5-deficient mice after wire injury. Thus, our findings suggest that DDX-5 knockdown in SMC exacerbates neointimal thickening in response to injury in vivo.
DDX-5 Regulates GATA-6 Expression and Vascular Remodeling in Balloon-Injured Rat Carotid Arteries
To test the hypothesis that DDX-5 is a potential therapeutic target for vascular remodeling, we used rat carotid artery balloon injury model and measured the neointimal formation 2 weeks after angioplasty. GFP or DDX-5 lentivirus was intraartery infused as previously described.
11 Two weeks after transduction, it was demonstrated a marked elevation of DDX-5 expression compared with GFP virus-treated group, as determined by Western blot analysis ( Figure 8A ). There was no neointimal formation in the sham-control carotid arteries ( Figure 8B ). In control rats, balloon injury resulted in a substantial enlargement of neointimal lesions, which significantly reduced the lumen of the vessel. Restoration of the downregulated DDX-5 via DDX-5 virus transduction, however, inhibited neointimal lesion formation significantly in balloon-injured rat carotid arteries, which was associated with decreases in both the neointimal area and the intima-tomedia ratio, compared with the control group ( Figure 8C and  8D) . By contrast, GFP lentivirus did not significantly alter vascular remodeling after balloon injury.
To determine if DDX-5 overexpression protected SMCs from injury-triggered proliferation in vivo, we detected PCNA expression in GFP-and DDX-5 lentivirus-transducted rat carotid arteries undergoing balloon injury. Similar to the findings from mouse femoral artery injury study, in the carotid arteries treated with DDX-5 lentivirus, a significantly lower PCNA protein level in the neointimal area was observed compared with control carotid vessels, as determined by Western blot and immunofluorescence assay ( Figure 8A and 8E). In accordance, DDX-5 restoration upregulated GATA-6 and p27
Kip1 expression compared to the GFP lentivirus-treated injured arteries, as shown in Figure 8A , 8F, and 8G. In addition, we found a weaker interaction between DDX-5 and GATA-6 in the injured rat carotid arteries, which was restored by DDX-5 virus transduction (Online Figure  XIIA) . Likewise, in vivo overexpression of DDX-5 reversed balloon injury-induced repression of the GATA-6 recruitment to p27
Kip1 promoter (Online Figure XIIB) . Therefore, the data indicate that upregulation of DDX-5 attenuates SMC proliferation and neointima formation in rat carotid artery after angioplasty.
Discussion
In the present study, we have shown that DDX-5, the most abundantly expressed RNA helicase DEAD-box protein in human and rodent arteries, antagonizes SMC proliferation and migration, and suppresses vascular remodeling after injury. The mechanism underlying this process is due to a novel pathway that DDX-5 directly binds to GATA-6 protein and maintains its expression by avoiding MDM-2-mediated degradation. DDX-5 upregulates p27
Kip1 expression through GATA-6, which interacts directly with p27
Kip1 promoter and enhances its transcription. Our data are demonstrative of the importance of RNA helicase DDX-5 in SMC biological function and vascular pathology and suggest that DDX-5 is a Kip1 , and proliferating cell nuclear antigen (PCNA) in rat carotid arteries were assessed by Western blot analysis (n=6; 1-way ANOVA; *P<0.05). B-D, Hematoxylin and eosin staining on sections of rat carotid arteries at 14 d after injury (B). Effect of DDX-5 overexpression on vascular neointimal lesion formation in rat carotid arteries was quantitated by neointima/media ratio (Continued ) Figure 7 Continued. (E; n=8 per group; 2-tailed Student t test; *P<0.05). F, Control and DDX-5 SMC-KO mice were exposed to a femoral artery wire injury. Protein levels of GATA (GATA-binding protein)-6, p27 Kip1 , and proliferating cell nuclear antigen (PCNA) in mouse femoral arteries were assessed by Western blot analysis (n=5; 1-way ANOVA; *P<0.05 compared with control group, #P<0.05 compared with control+injury group). G-I, Wire-injured femoral arteries in control and SMC-specific DDX-5-deficient mice were stained with antibody against PCNA (G), GATA-6 (H), and p27
Kip1 (I). The white line indicated the boundary between the intima and the media (n=4). Scale bars=20 μm.
potential target for vascular therapies aimed at inhibiting SMC proliferation, such as antiatherogenesis and antirestenosis.
RNA helicases are highly conserved enzymes involved in nearly all aspects of RNA metabolism. They use ATP to unwind RNA and are capable of disrupting RNA-protein interactions and remodeling ribonucleoproteins. 1 Moreover, recent studies have demonstrated that RNA helicases play a role in a range of different processes besides RNA manipulation, suggesting that these proteins possess multiple functions. Several RNA helicases have been implicated in the regulation of cell growth and organ differentiation, through interaction with partner proteins. 31 Therefore, for the first time, we explore the potential association between RNA helicases and vascular disease.
The current study focused on RNA helicase DEAD-box proteins that form the largest helicase family. We found that among them, DDX-5 had the highest expression in mammal vessel, and presented mainly in vascular SMCs. In addition, we demonstrated decreased DDX-5 level in aberrantly activated SMCs, not only under in vitro culture conditions but also in vivo in vascular lesions from rat carotid artery injury model and diseased human vessels. More importantly, we have provided in vitro and in vivo evidence that DDX-5 had essential role in SMC growth, migration, and vascular remodeling, which seemed to be independent of the RNA helicase activity. The protective role of DDX-5 in SMC proliferation is in accordance with our previous study that reveals its important role in SMC homeostasis, but still relatively surprising, because a large body of literature shows that DDX-5 is growth-promoting and crucial for cancer development. [5] [6] [7] [8] The inconsistency of DDX-5 biological function in benign lesion and malignant tumor is curious, which makes us to further explore the underlying mechanism.
GATA factors are zinc finger DNA-binding proteins control development of diverse tissues by modulating transcription. 32, 33 GATA transcription factor family comprises 6 vertebrate genes, which characterized by their ability to interact with a consensus A/T GATA A/G or related sequence. 34, 35 Among them, GATA-6 is the only member expressed in the medial SMCs of the vasculature. 36 Several studies reported that GATA-6 is essential for maintaining the contractile SMC phenotype. 26, 37 Overexpression of GATA-6 has been shown Figure 8 Continued. (C) and neointimal area (D; n=8 per group; 2-tailed Student t test; *P<0.05 compared with GFP virus). Scale bars=50 μm. E-G, Ballooninjured rat carotid arteries treated with GFP and DDX-5 lentivirus were stained with antibody against PCNA (E), GATA-6 (F), and p27 Kip1 (G). The white line indicated the boundary between the intima and the media (n=4). Scale bars=50 μm.
to induce cell cycle arrest in both SMCs and fibroblasts. 38 Conversely, recent researches have indicated that GATA-6 is required for tumor cell expansion and promotes carcinogenesis and metastasis. The discordant phenomena are in harmony with our observation on DDX-5, thus we postulated that DDX-5 functions through modulating GATA-6.
Despite the majority of the related researches that identified GATA-6 as a negative regulator of cellular growth and vascular remodeling, GATA-6 has been documented to be an enhancer of rat SMC hypertrophy and hyperplasia in a very recent publication. 30 In this study, we confirmed the negative correlation between GATA-6 and proliferation of human vascular SMCs, and we demonstrated that GATA-6 could inhibit SMC migration. Furthermore, we defined a novel mechanism by which DDX-5 positively regulated GATA-6 expression, through a direct interaction with GATA-6 and preventing its degradation mediated by its E3 ubiquitin ligase-MDM-2. Therefore, DDX-5 is a molecular partner of GATA-6 and can serve as a crucial multifunctional mediator in SMCs, through regulating GATA-6.
In delineating how DDX-5 functioned through GATA-6 in SMCs, we initially focused our attention on p21
Cip1
, which plays an important role in neointimal hyperplasia as a cyclindependent kinase inhibitor for SMCs. 21, 22 Previous study has also shown that GATA-6 represses glomerular mesangial cell proliferation by upregulation of p21
. 39 However, we failed to detect any difference in p21
Cip1 protein levels between SMCs transfected with either DDX-5 siRNA or overexpression lentivirus and the corresponding control cells, thus DDX-5 had no regulatory effects on p21
Cip1 in SMCs. It should be noted that previous studies have found that serum stimuli enhanced p21 Cip1 expression, indicating that p21
Cip1 was needed for SMC survival and proliferation. 40 , 41 Bond et al 42 reported that p21 Cip1 controls SMC proliferation in a biphasic manner, which also suggests the uncertain association between p21
Cip1 and cell cycle arrest in SMCs. Other studies have identified p21
Cip1 as a positive regulatory effector that was responsible for SMC proliferation. 43, 44 It has been shown that proproliferative stimulus decreased p27 Kip1 and increased p21
Cip1 in SMCs, 40 hence, we hypothesized that DDX-5 might regulate SMC biological function through p27 Kip1 , but not p21 Cip1 . Interestingly, our data demonstrated that both DDX-5 and GATA-6 were positively associated with p27
Kip1 mRNA and protein expressions. Moreover, DDX-5-induced inhibition of SMC proliferation and migration was, at least partially, through upregulation of p27
Kip1 level via GATA-6. Remarkably, we were the first to demonstrate the novel protein-RNA interplay between GATA-6 and p27
Kip1 promoter. Furthermore, DDX-5 was capable of increasing the binding of GATA-6 to p27
Kip1 promoter and subsequently increased p27 Kip1 RNA transcription. However, future studies are needed to understand whether DDX-5 increased GATA-6 at p27 Kip1 promoter by enhancing its binding capacity, besides upregulating GATA-6 protein level. Furthermore, GATA-6/p27
Kip1 pathway might only partiality account for the protective effects of DDX-5 on SMC proliferation, given its strong biological property.
Notably, we showed that smooth muscle selective DDX-5 deletion in mice resulted in enhanced growth and migration of SMCs, and a substantial increase in the neointima of the injured femoral artery. In contrast, overexpression of DDX-5 inhibited vascular remodeling in rat carotid artery after balloon insertion. Interestingly, SMC-specific DDX-5-deficient mice exhibit no significant changes in vascular structure basally, which indicated that loss of DDX-5 could be extremely detrimental for injury-stimulated SMC misbehavior and the subsequent vascular remodeling, but no major influence on vascular structure during the development of the vessel, indicating a difference of SMCs in the formation of the vessel and neointimal lesions. In summary, we have demonstrated that DDX-5 deletion promotes SMC proliferation and is critical for neointimal formation after vascular injury. GATA-6 is the key downstream effector molecule of DDX-5 and at least partially mediates its protective effects in arteries. DDX-5 may emerge as a promising potent therapeutic target in vascular diseases involving aberrant proliferation of SMC.
